Nitrosamine-free pharmaceuticals

Address nitrosamine risk mitigation with confidence

nitrite scavengers poster screenshot
Are nitrosamines a concern in your drug products?

Navigating nitrosamine risk mitigation is an unprecedented challenge for the pharmaceutical industry. We are here to provide high quality antioxidants and technical expertise to help you succeed in addressing nitrosamines in your drug products. Ascorbic acid has proven efficacy in scavenging nitrites and preventing nitrosamine formation in a model formulation, in concentrations as low as 0.25% and is a safe and easy-to-use solution in direct compression or wet granulation processes.

Discover the latest science: Ascorbic acid significantly reduces nitrosamine formation in drug products

Our new clinical research unveils compelling evidence of ascorbic acid's remarkable ability to scavenge nitrites and inhibit nitrosamine accumulation, even at concentrations as low as 0.25%. Download our latest scientific poster to explore this promising method of mitigating nitrosamine risk in pharmaceuticals. 

vitamins image
Nitrite scavengers - An elegant and simple solution to mitigate nitrosamines in drug products

With looming deadlines set by governmental bodies, all pharmaceutical companies must assess and control nitrosamine content in their drug products. Solutions are often multi-layered and may include simple and safe nitrite scavengers in the final drug formulation. In this AAPS e-chalk talk dsm-firmenich experts discuss key considerations for nitrosamine mitigation in drug products using nitrite scavengers.

Learning objectives:

  • Learn about nitrite scavengers of use for nitrosamine mitigation in drug products
  • Better understanding of key aspects when formulating with ascorbic acid and alpha-tocopherol
  • Case studies
Successful female asian scientist use microscope to check the experiments in the laboratory

Benefits of ascorbic acid for nitrosamine

Our whitepaper delves into the evolving nitrosamine regulations in the pharmaceutical market. Formulators face new guidelines, necessitating a reevaluation of formulations prone to nitrosamine formation. Developing mitigation strategies is critical for future pharmaceutical safety. Ascorbic acid and alpha-tocopherol offer promising solutions.
Think nitrosamine mitigation. Think dsm-firmenich.

Overcoming critical formulation challenges takes more than adding ingredients – it takes a reliable partner. Whether it’s supporting you with the reformulation of your existing drug product, or helping to bring new innovative therapies to market, we can assist you in implementing a proven mitigation strategy to reduce the risk of nitrosamine formation in your pharmaceuticals.

Industry-leading API portfolio and formulation expertise

With over 70 years of experience, dsm-firmenich produces reliable vitamin APIs and excipients in GMP-certified facilities. Trust our pharmaceutical grade ascorbic acid and alpha-tocopherol excipients.

Scientific knowledge

We have the scientific know-how and cutting-edge technology you need to mitigate the risk of nitrosamines in your oral solid, semisolid, liquid or injectable formulations.

Regulatory insight

Our excipient production is governed by a wide range of global certification systems to support the success of your pharmaceutical solutions, including GMP, CEPs, DMFs and compliance with multiple pharmacopeia.

Related articles
  • Ask the expert: how can ascorbic acid help mitigate nitrosamine risk in drug products?
    Ask the expert: how can ascorbic acid help mitigate nitrosamine risk in drug products?

    Ascorbic acid, and other nitrite scavengers, have been shown to act as functional excipients in drug products that can reduce nitrosamine formation by blocking nitrosation reactions.

  • Nitrite scavengers for nitrosamine mitigation: expert takeaways from dsm-firmenich’s AAPS eChalk Talk
    Nitrite scavengers for nitrosamine mitigation: expert takeaways from dsm-firmenich’s AAPS eChalk Talk

    Discover the latest insights on nitrosamine risk mitigation presented by dsm-firmenich during an eChalk Talk hosted by the American Association of Pharmaceutical Scientists (AAPS).

  • Nitrite Scavengers - An elegant and simple solution to mitigate nitrosamines in drug products
    Nitrite Scavengers - An elegant and simple solution to mitigate nitrosamines in drug products

    In this AAPS e-chalk talk dsm-firmenich experts discuss key considerations for nitrosamine mitigation in drug products using nitrite scavengers.

We are an ideal partner for purposeful improvements and advancements in the pharmaceutical space. To learn more about our advanced formulation expertise and solutions for nitrosamine mitigation, connect with one of our experts today. 
 
Personal Information
✓ Valid
Company Information
Communications Preferences
Terms and conditions
Stay up to date
,